Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Therma Bright Inc TBRIF


Primary Symbol: V.THRM

Healthcare Medical Devices
Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

Recent & Breaking News (TSXV:THRM)

Therma Bright Inc. Invests in Ischemic Stroke Blood Clot Retriever Technology Company Inretio Inc. based in Israel

Newsfile January 19, 2023

Therma Bright Provides 2022 Year End Update

Newsfile December 21, 2022

Therma Bright (TSXV:THRM) invests in inhalable statin technology

Trevor Abes  December 1, 2022

Therma Bright Invests in the Development of Novel Treatments for COVID-19, Asthma, and Chronic Obstructive Pulmonary Disease (COPD)

Newsfile December 1, 2022

Therma Bright (TSXV:THRM) to acquire exclusive licensing rights for a digital cough-based diagnosis screening technology

John Ballem  November 17, 2022

Therma Bright Inc. to Acquire an Exclusive License for a Patented Digital Cough Based Technology to Detect Respiratory Diseases

Newsfile November 17, 2022

Therma Bright (TSXV:THRM) announces expedited insurance reimbursements for Venowave

Trevor Abes  October 27, 2022

Therma Bright Receives New Billing Codes for Venowave Allowing for Reimbursement from Medicare, Medicaid, and Private Insurers

Newsfile October 27, 2022

Therma Bright Receives Payment for Initial Venowave Sales

Newsfile September 20, 2022

Therma Bright (TSXV:THRM) updates on FDA EUA review

Jonathon Brown September 12, 2022

Therma Bright Provides Update on FDA EUA Review Process

Newsfile September 12, 2022

Therma Bright (TSXV:THRM) updates on antigen test

Caroline Egan  August 4, 2022

Therma Bright Provides Progress Update on FDA EUA & Health Canada Interim Order Applications for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test

Newsfile August 4, 2022

Therma Bright (TSXV:THRM) waits to hear back from Health Canada

Brieanna McCutcheon  June 23, 2022

Therma Bright Submits Health Canada Application for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test for Point-of-Care (POC)

Newsfile June 23, 2022

Therma Bright Grants Stock Options

Newsfile June 10, 2022

Therma Bright (TSXV:THRM) retools FDA EUA application for AcuVid COVID-19 Rapid Antigen Saliva Test

Brieanna McCutcheon  June 2, 2022

Therma Bright Provides Update on FDA EUA Application Process For AcuVid(TM) COVID-19 Rapid Antigen Saliva Test

Newsfile June 2, 2022

Therma Bright (TSXV:THRM) applies for approval of its AcuVid COVID-19 Rapid Antigen Saliva Test

John Ballem  May 10, 2022

Therma Bright to Submit Application to Health Canada for Approval of its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test

Newsfile May 10, 2022